Xeris Biopharma Holdings, Inc. (XERS)
6.37
+0.25
(+4.08%)
USD |
NASDAQ |
Apr 17, 16:00
6.37
0.00 (0.00%)
After-Hours: 05:13
Xeris Biopharma Holdings SG&A Expense (Quarterly) : 47.50M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 275.68M |
| Zoetis, Inc. | 619.00M |
| Harrow, Inc. | 43.31M |
| Zymeworks, Inc. | 15.43M |
| Vir Biotechnology, Inc. | 23.62M |